A Phase 1, Open Label, Randomized, Four Period, Crossover, Multiple Dose Study To Assess The Pharmacokinetic Interaction Between Sitaxsentan and Tadalafil and The Effect Of Sildenafil On Sitaxsentan PK In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2012
At a glance
- Drugs Sildenafil; Sitaxentan; Tadalafil
- Indications Erectile dysfunction; Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Pfizer
- 13 Dec 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Dec 2010 New trial record